Protein kinase inhibitors that inhibit induction of lytic program and replication of Epstein–Barr virus

Adamson, 1998, Rescue of the Epstein–Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product, Virology, 251, 187, 10.1006/viro.1998.9396 Arcaro, 1993, Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses, Biochem. J., 296, 297, 10.1042/bj2960297 Asai, 2006, Epstein–Barr virus protein kinase BGLF4 is a virion tegument protein that dissociates from virions in a phosphorylation-dependent process and phosphorylates the viral immediate–early protein BZLF1, J. Virol., 80, 5125, 10.1128/JVI.02674-05 Bahlis, 2005, N-Benzoylstaurosporine (PKC412) inhibits Akt kinase inducing apoptosis in multiple myeloma cells, Leuk. Lymphoma, 46, 899, 10.1080/10428190500080595 Bertrand, 1994, Induction of a common pathway of apoptosis by staurosporine, Exp. Cell Res., 211, 314, 10.1006/excr.1994.1093 Bilder, 1991, Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells, Am. J. Physiol., 260, C721, 10.1152/ajpcell.1991.260.4.C721 Biron, 2002, Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole l-riboside with a unique mode of action, Antimicrob. Agents Chemother., 46, 2365, 10.1128/AAC.46.8.2365-2372.2002 Brown, 2003, NF-kappaB inhibits gammaherpesvirus lytic replication, J. Virol., 77, 8532, 10.1128/JVI.77.15.8532-8540.2003 Chen, 2000, A protein kinase activity associated with Epstein–Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro, J. Virol., 74, 3093, 10.1128/JVI.74.7.3093-3104.2000 Chin, 1999, K252a induces cell cycle arrest and apoptosis by inhibiting Cdc2 and Cdc25c, Cancer Invest., 17, 391, 10.3109/07357909909021430 Daibata, 1990, Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt’s lymphoma cell line Akata, J. Immunol., 144, 4788, 10.4049/jimmunol.144.12.4788 Daikoku, 1997, Purification and characterization of the protein kinase encoded by the UL13 gene of herpes simplex virus type 2, Virology, 235, 82, 10.1006/viro.1997.8653 Dal Porto, 2004, B cell antigen receptor signaling 101, Mol. Immunol., 41, 599, 10.1016/j.molimm.2004.04.008 Darr, 2001, Epstein–Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation, J. Virol., 75, 6135, 10.1128/JVI.75.13.6135-6142.2001 Davies, 1991, Induction of Epstein–Barr virus lytic cycle by tumor-promoting and non-tumor-promoting phorbol esters requires active protein kinase C, J. Virol., 65, 6838, 10.1128/JVI.65.12.6838-6844.1991 Davies, 2000, Specificity and mechanism of action of some commonly used protein kinase inhibitors, Biochem. J., 351, 95, 10.1042/0264-6021:3510095 Fabbro, 2000, PKC412 – a protein kinase inhibitor with a broad therapeutic potential, Anticancer Drug Des., 15, 17 Fan, 2001, Epstein–Barr viral load measurement as a marker of EBV-related disease, Mol. Diagn., 6, 279, 10.2165/00066982-200106040-00009 Favata, 1998, Identification of a novel inhibitor of mitogen-activated protein kinase kinase, J. Biol. Chem., 273, 18623, 10.1074/jbc.273.29.18623 Feederle, 2000, The Epstein–Barr virus lytic program is controlled by the co-operative functions of two transactivators, EMBO J., 19, 3080, 10.1093/emboj/19.12.3080 Fox, 1998, A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase, Protein Sci., 7, 2249, 10.1002/pro.5560071102 Gao, 2001, 12-O-tetradecanoylphorbol-13-acetate induces Epstein–Barr virus reactivation via NF-kappaB and AP-1 as regulated by protein kinase C and mitogen-activated protein kinase, Virology, 286, 91, 10.1006/viro.2001.0965 Gershburg, 2004, Effects of maribavir and selected indolocarbazoles on Epstein–Barr virus protein kinase BGLF4 and on viral lytic replication, Antimicrob. Agents Chemother., 48, 1900, 10.1128/AAC.48.5.1900-1903.2004 Gershburg, 2002, Phosphorylation of the Epstein–Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the l-riboside benzimidazole 1263W94, J. Virol., 76, 998, 10.1128/JVI.76.3.998-1003.2002 Gershburg, 2008, Conserved herpesvirus protein kinases, Biochim. Biophys. Acta, 1784, 203, 10.1016/j.bbapap.2007.08.009 Gershburg, 2007, Epstein–Barr virus-encoded protein kinase (BGLF4) is involved in production of infectious virus, J. Virol., 81, 5407, 10.1128/JVI.02398-06 Gershburg, 2010, Key motifs in EBV (Epstein–Barr virus)-encoded protein kinase for phosphorylation activity and nuclear localization, Biochem. J., 431, 227, 10.1042/BJ20100558 Gschwendt, 1994, Rottlerin, a novel protein kinase inhibitor, Biochem. Biophys. Res. Commun., 199, 93, 10.1006/bbrc.1994.1199 Hamirally, 2009, Viral mimicry of Cdc2/cyclin-dependent kinase 1 mediates disruption of nuclear lamina during human cytomegalovirus nuclear egress, PLoS Pathog., 5, e1000275, 10.1371/journal.ppat.1000275 Han, 2000, The staurosporine analog, Ro-31-8220, induces apoptosis independently of its ability to inhibit protein kinase C, Cell Death Differ., 7, 521, 10.1038/sj.cdd.4400681 He, 1997, The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines, J. Virol., 71, 405, 10.1128/JVI.71.1.405-411.1997 Hers, 1999, The protein kinase C inhibitors bisindolylmaleimide I (GF 109203x) and IX (Ro 31-8220) are potent inhibitors of glycogen synthase kinase-3 activity, FEBS Lett., 460, 433, 10.1016/S0014-5793(99)01389-7 Iwakiri, 2004, Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein–Barr virus activation, J. Immunol., 172, 1561, 10.4049/jimmunol.172.3.1561 Jacob, 2011, Viral serine/threonine protein kinases, J. Virol., 85, 1158, 10.1128/JVI.01369-10 Johnson, 2002, Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases, Science, 298, 1911, 10.1126/science.1072682 Kawaguchi, 2003, Protein kinases conserved in herpesviruses potentially share a function mimicking the cellular protein kinase cdc2, Rev. Med. Virol., 13, 331, 10.1002/rmv.402 Kieff, 2007, Epstein–Barr virus and its replication, 2603 Kurosaki, 2010, B cell signaling and fate decision, Annu. Rev. Immunol., 28, 21, 10.1146/annurev.immunol.021908.132541 Lazdins, 1987, TPA induction of Epstein–Barr virus early antigens in Raji cells is blocked by selective protein kinase-C inhibitors, Int. J. Cancer, 40, 846, 10.1002/ijc.2910400624 Liu, 2008, NF-kappaB inhibitors induce lytic cytotoxicity in Epstein–Barr virus-positive nasopharyngeal carcinoma cells, Cell Biol. Int., 32, 1006, 10.1016/j.cellbi.2008.03.022 Marschall, 2002, Direct targeting of human cytomegalovirus protein kinase pUL97 by kinase inhibitors is a novel principle for antiviral therapy, J. Gen. Virol., 83, 1013, 10.1099/0022-1317-83-5-1013 Massillon, 1994, Identification of the glycogenic compound 5-iodotubercidin as a general protein kinase inhibitor, Biochem. J., 299, 123, 10.1042/bj2990123 McKenna, 1993, Inhibition by Ro 31-8220 of acid secretory activity induced by carbachol indicates a stimulatory role for protein kinase C in the action of muscarinic agonists on isolated rat parietal cells, Biochem. Pharmacol., 46, 583, 10.1016/0006-2952(93)90541-4 Mori, 2006, Functional role of phosphatidylinositol 3-kinase/Akt pathway on cell growth and lytic cycle of Epstein–Barr virus in the Burkitt’s lymphoma cell line, P3HR-1, Virus Genes, 32, 327, 10.1007/s11262-005-6918-9 Murata, 2009, Efficient production of infectious viruses requires enzymatic activity of Epstein–Barr virus protein kinase, Virology, 389, 75, 10.1016/j.virol.2009.04.007 Oussaief, 2011, NF-kappaB-mediated modulation of inducible nitric oxide synthase activity controls induction of the Epstein–Barr virus productive cycle by transforming growth factor beta 1, J. Virol., 85, 6502, 10.1128/JVI.02560-10 Overton, 1992, Herpes simplex virus type 1 gene UL13 encodes a phosphoprotein that is a component of the virion, Virology, 190, 184, 10.1016/0042-6822(92)91204-8 Palumbo, 1997, The tyrphostin AG17 induces apoptosis and inhibition of cdk2 activity in a lymphoma cell line that overexpresses bcl-2, Cancer Res., 57, 2434 Peng, 2010, Inhibition of the phosphatidylinositol 3-kinase-Akt pathway enhances gamma-2 herpesvirus lytic replication and facilitates reactivation from latency, J. Gen. Virol., 91, 463, 10.1099/vir.0.015073-0 Pierce, 1997, Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo, J. Biol. Chem., 272, 21096, 10.1074/jbc.272.34.21096 Prichard, 1999, A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency, J. Virol., 73, 5663, 10.1128/JVI.73.7.5663-5670.1999 Rickinson, 2007, Epstein–Barr virus, 2655 Ringshausen, 2006, Mechanisms of apoptosis-induction by rottlerin: therapeutic implications for B-CLL, Leukemia, 20, 514, 10.1038/sj.leu.2404113 Satoh, 1999, The interaction of mitogen-activated protein kinases to Epstein–Barr virus activation in Akata cells, Virus Genes, 18, 57, 10.1023/A:1008021402908 Schultz, 1999, Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity, J. Med. Chem., 42, 2909, 10.1021/jm9900570 Takada, 1984, Cross-linking of cell surface immunoglobulins induces Epstein–Barr virus in Burkitt lymphoma lines, Int. J. Cancer, 33, 27, 10.1002/ijc.2910330106 Takada, 1991, An Epstein–Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA, Virus Genes, 5, 147, 10.1007/BF00571929 Tovey, 1978, Activation of latent Epstein–Barr virus by antibody to human IgM, Nature, 276, 270, 10.1038/276270a0 Umezawa, 1990, Inhibition of epidermal growth factor-induced DNA synthesis by tyrosine kinase inhibitors, FEBS Lett., 260, 198, 10.1016/0014-5793(90)80102-O van Zeijl, 1997, The human cytomegalovirus UL97 protein is phosphorylated and a component of virions, Virology, 231, 72, 10.1006/viro.1997.8523 Vlahos, 1994, A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002), J. Biol. Chem., 269, 5241, 10.1016/S0021-9258(17)37680-9 Wang, 2009, Maribavir inhibits Epstein-Barr viral transcription in addition to viral DNA replication, J Virol., 83, 12108, 10.1128/JVI.01575-09 Williams, 2003, In vitro activities of benzimidazole d- and l-ribonucleosides against herpesviruses, Antimicrob. Agents Chemother., 47, 2186, 10.1128/AAC.47.7.2186-2192.2003 Wymann, 1996, Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction, Mol. Cell. Biol., 16, 1722, 10.1128/MCB.16.4.1722 Zacny, 1999, Inhibition of Epstein–Barr virus replication by a benzimidazole l-riboside: novel antiviral mechanism of 5,6-dichloro-2-(isopropylamino)-1-beta-l-ribofuranosyl-1H-benzimidazole, J. Virol., 73, 7271, 10.1128/JVI.73.9.7271-7277.1999 Zaharevitz, 1999, Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases, Cancer Res., 59, 2566